Limb ischemia and vessel regeneration: Is there a role for VEGF? (Q38952702)

7 September 2017

1 reference

title

Limb ischemia and vessel regeneration: Is there a role for VEGF? (English)

1 reference

7 September 2017

1 reference

Anna Grochot-Przęczek

series ordinal

3

object named as

Anna Grochot-Przeczek

1 reference

7 September 2017

6

Alicja Jozkowicz

1 reference

7 September 2017

7

Jozef Dulak

1 reference

7 September 2017

5

Agnieszka Loboda

1 reference

7 September 2017

2

Urszula Florczyk

1 reference

7 September 2017

Agnieszka Jaźwa-Kusior

series ordinal

1

object named as

Agnieszka Jazwa

1 reference

7 September 2017

4

Bart Krist

1 reference

7 September 2017

publication date

9 September 2016

1 reference

7 September 2017

published in

Vascular Pharmacology

1 reference

7 September 2017

volume

86

1 reference

7 September 2017

page(s)

18-30

1 reference

Peripheral arterial disease of the lower extremities

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Therapeutic angiogenesis for revascularization in peripheral artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Mechanisms of angiogenesis and arteriogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Collateral circulation: past and present

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Stimulation of arteriogenesis; a new concept for the treatment of arterial occlusive disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Therapeutic angiogenesis. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Factors regulating arteriogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Contribution of arteriogenesis and angiogenesis to postocclusive hindlimb perfusion in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Evaluation of postnatal arteriogenesis and angiogenesis in a mouse model of hind-limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Cardiovascular gene therapy with vascular endothelial growth factors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Bone marrow origin of endothelial progenitor cells responsible for postnatal vasculogenesis in physiological and pathological neovascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Bone marrow-derived cells do not incorporate into the adult growing vasculature.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Endothelial progenitor cells--an evolving story

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Exercise promotes collateral artery growth mediated by monocytic nitric oxide

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

The biology of VEGF and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Effect of heme and heme oxygenase-1 on vascular endothelial growth factor synthesis and angiogenic potency of human keratinocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Nitric oxide induces the synthesis of vascular endothelial growth factor by rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Expansion and characterization of neonatal cardiac pericytes provides a novel cellular option for tissue engineering in congenital heart disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Angiogenesis in life, disease and medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Roles of two VEGF receptors, Flt-1 and KDR, in the signal transduction of VEGF effects in human vascular endothelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial growth factor receptor Flt-1 negatively regulates developmental blood vessel formation by modulating endothelial cell division.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF165b, an inhibitory vascular endothelial growth factor splice variant: mechanism of action, in vivo effect on angiogenesis and endogenous protein expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Molecular regulation of angiogenesis and lymphangiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Basic and therapeutic aspects of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Endothelial cells dynamically compete for the tip cell position during angiogenic sprouting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGFRs and Notch: a dynamic collaboration in vascular patterning

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Autocrine VEGF signaling is required for vascular homeostasis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Autocrine VEGF maintains endothelial survival through regulation of metabolism and autophagy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Spatially restricted patterning cues provided by heparin-binding VEGF-A control blood vessel branching morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

To sprout or to split? VEGF, Notch and vascular morphogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF over-expression in skeletal muscle induces angiogenesis by intussusception rather than sprouting.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Role of ischemia and of hypoxia-inducible genes in arteriogenesis after femoral artery occlusion in the rabbit

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Blood flow remodels growing vasculature during vascular endothelial growth factor gene therapy and determines between capillary arterialization and sprouting angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Adenoviral gene transfer with soluble vascular endothelial growth factor receptors impairs angiogenesis and perfusion in a murine model of hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF receptor antagonism blocks arteriogenesis, but only partially inhibits angiogenesis, in skeletal muscle of exercise-trained rats

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial growth factor is required for coronary collateral growth in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

HIF-1 and HIF-2 transcription factors--similar but not identical

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Proline hydroxylation and gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

HIF-1 versus HIF-2--is one more important than the other?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Hypoxic induction of vascular endothelial growth factor (VEGF) in human epithelial cells is mediated by increases in mRNA stability

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

A stress-responsive RNA switch regulates VEGFA expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Tristetraprolin inhibits Ras-dependent tumor vascularization by inducing vascular endothelial growth factor mRNA degradation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

AUF1/hnRNP D represses expression of VEGF in macrophages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Hypoxic stabilization of vascular endothelial growth factor mRNA by the RNA-binding protein HuR

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

MicroRNA control of vascular endothelial growth factor signaling output during vascular development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Hypoxia-responsive miRNAs target argonaute 1 to promote angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Computational Model of MicroRNA Control of HIF-VEGF Pathway: Insights into the Pathophysiology of Ischemic Vascular Disease and Cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial cell-specific microRNA-15a inhibits angiogenesis in hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Cellular oxygen sensing, signalling and how to survive translational arrest in hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Systemic hypoxia changes the organ-specific distribution of vascular endothelial growth factor and its receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Regulation of hypoxia-inducible factor-1alpha by NF-kappaB

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Accumulation of HIF-1alpha under the influence of nitric oxide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Bacterial lipopolysaccharide induces HIF-1 activation in human monocytes via p44/42 MAPK and NF-kappaB.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

IL-1beta-mediated up-regulation of HIF-1alpha via an NFkappaB/COX-2 pathway identifies HIF-1 as a critical link between inflammation and oncogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

The proinflammatory cytokine interleukin 1beta and hypoxia cooperatively induce the expression of adrenomedullin in ovarian carcinoma cells through hypoxia inducible factor 1 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Hypoxia-inducible factor induction by tumour necrosis factor in normoxic cells requires receptor-interacting protein-dependent nuclear factor kappa B activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Gene transfer of CuZn superoxide dismutase enhances the synthesis of vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Regulation of hypoxia-inducible factor-1alpha by nitric oxide through mitochondria-dependent and -independent pathways.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Genetic augmentation of nitric oxide synthase increases the vascular generation of VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Angiogenesis Induced by Endothelial Nitric Oxide Synthase Gene Through Vascular Endothelial Growth Factor Expression in a Rat Hindlimb Ischemia Model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Adaptation of skeletal muscle microvasculature to increased or decreased blood flow: role of shear stress, nitric oxide and vascular endothelial growth factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Muscle-derived vascular endothelial growth factor regulates microvascular remodelling in response to increased shear stress in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Measurement of free and complexed soluble vascular endothelial growth factor receptor, Flt-1, in fluid samples: development and application of two new immunoassays

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Analysis of G(-174)C IL-6 polymorphism and plasma concentrations of inflammatory markers in patients with type 2 diabetes and peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Impact of type 2 diabetes on the plasma levels of vascular endothelial growth factor and its soluble receptors type 1 and type 2 in patients with peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial growth factor and its receptor, Flt-1, in the plasma of patients with coronary or peripheral atherosclerosis, or Type II diabetes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Plasma levels of soluble Tie2 and vascular endothelial growth factor distinguish critical limb ischemia from intermittent claudication in patients with peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Dysfunctional vasa vasorum in diabetic peripheral artery obstructive disease with critical lower limb ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Impact of VEGF polymorphisms on the severity of peripheral artery disease in diabetic patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF: a surrogate marker for peripheral vascular disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF and VEGF receptor expression in human chronic critical limb ischaemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Expression of Vascular Endothelial Growth Factor, Stromal Cell-Derived Factor-1, and CXCR4 in Human Limb Muscle With Acute and Chronic Ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Antiangiogenic VEGF-A in peripheral artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

An antiangiogenic isoform of VEGF-A contributes to impaired vascularization in peripheral artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Alteration in angiogenic and anti-angiogenic forms of vascular endothelial growth factor-A in skeletal muscle of patients with intermittent claudication following exercise training

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Angiogenic response to passive movement and active exercise in individuals with peripheral arterial disease.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Impaired vascular endothelial growth factor A and inflammation in patients with peripheral artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial cell growth factor and fibroblast growth factor 2 expression in patients with critical limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Evaluation of the clinical relevance and limitations of current pre-clinical models of peripheral artery disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Angiogenic gene therapy for experimental critical limb ischemia: acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Sustained VEGF delivery via PLGA nanoparticles promotes vascular growth

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Umbilical cord blood-derived aldehyde dehydrogenase-expressing progenitor cells promote recovery from acute ischemic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Arteriogenic therapy based on simultaneous delivery of VEGF-A and FGF4 genes improves the recovery from acute limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Pre-emptive hypoxia-regulated HO-1 gene therapy improves post-ischaemic limb perfusion and tissue regeneration in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Genetic background influences therapeutic effectiveness of VEGF

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Collateral density, remodeling, and VEGF-A expression differ widely between mouse strains

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Age-dependent impairment of angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

S100A1 deficiency impairs postischemic angiogenesis via compromised proangiogenic endothelial cell function and nitric oxide synthase regulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Impaired collateral vessel development associated with reduced expression of vascular endothelial growth factor in ApoE-/- mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Impaired angiogenesis after hindlimb ischemia in type 2 diabetes mellitus: differential regulation of vascular endothelial growth factor receptor 1 and soluble vascular endothelial growth factor receptor 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Differential expression of Flk-1 and Flt-1 in rat skeletal muscle in response to chronic ischaemia: favourable effect of muscle activity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial growth factor modulates skeletal myoblast function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular growth factor expression in a rat model of severe limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Muscle fiber characteristics in patients with peripheral arterial disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Standardized Induction of Myocardial Ischaemia in the Dog

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Angiogenic therapy for the chronically ischemic lower limb in a rabbit model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

The effect of gradual or acute arterial occlusion on skeletal muscle blood flow, arteriogenesis, and inflammation in rat hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Cellular and molecular mechanism regulating blood flow recovery in acute versus gradual femoral artery occlusion are distinct in the mouse

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Site-specific therapeutic angiogenesis after systemic administration of vascular endothelial growth factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial growth factor augments muscle blood flow and function in a rabbit model of chronic hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial growth factors: biology and current status of clinical applications in cardiovascular medicine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Therapeutic angiogenesis in ischemic heart disease: gene or recombinant vascular growth factor protein therapy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Therapeutic angiogenesis following arterial gene transfer of vascular endothelial growth factor in a rabbit model of hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Endothelium-dependent relaxation of collateral microvessels after intramuscular gene transfer of vascular endothelial growth factor in a rat model of hindlimb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Direct intramuscular gene transfer of naked DNA encoding vascular endothelial growth factor augments collateral development and tissue perfusion

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Delivery of high dose VEGF plasmid using fibrin carrier does not influence its angiogenic potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Clinical evidence of angiogenesis after arterial gene transfer of phVEGF165 in patient with ischaemic limb

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Increased vascularity detected by digital subtraction angiography after VEGF gene transfer to human lower limb artery: a randomized, placebo-controlled, double-blinded phase II study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Constitutive expression of phVEGF165 after intramuscular gene transfer promotes collateral vessel development in patients with critical limb ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Treatment with intramuscular vascular endothelial growth factor gene compared with placebo for patients with diabetes mellitus and critical limb ischemia: a double-blind randomized trial.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Fibroblast growth factor 4 induces vascular permeability, angiogenesis and arteriogenesis in a rabbit hindlimb ischemia model

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Rescue of diabetes-related impairment of angiogenesis by intramuscular gene therapy with adeno-VEGF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Evaluation of angiogenesis and side effects in ischemic rabbit hindlimbs after intramuscular injection of adenoviral vectors encoding VEGF and LacZ.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Regional Angiogenesis with Vascular Endothelial Growth Factor (VEGF) in peripheral arterial disease: Design of the RAVE trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin-1 monocyte/TGF-β1 paracrine axis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Ultrasound imaging with bolus delivered contrast agent for the detection of angiogenesis and blood flow irregularities

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

7 January 2021

The well-tempered vessel

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Conditional switching of VEGF provides new insights into adult neovascularization and pro-angiogenic therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

VEGF gene delivery to myocardium: deleterious effects of unregulated expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Long-term VEGF-A expression promotes aberrant angiogenesis and fibrosis in skeletal muscle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

HIF-regulated HO-1 gene transfer improves the post-ischemic limb recovery and diminishes TLR-triggered immune responses - Effects modified by concomitant VEGF overexpression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Sustained improvement in perfusion and flow reserve after temporally separated delivery of vascular endothelial growth factor and angiopoietin-1 plasmid deoxyribonucleic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Induction of functional neovascularization by combined VEGF and angiopoietin-1 gene transfer using AAV vectors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Coadministration of angiopoietin-1 and vascular endothelial growth factor enhances collateral vascularization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Polymeric system for dual growth factor delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Cotransfection of vascular endothelial growth factor-A and platelet-derived growth factor-B via recombinant adeno-associated virus resolves chronic ischemic malperfusion role of vessel maturation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Vascular endothelial growth factor-A and platelet-derived growth factor-B combination gene therapy prolongs angiogenic effects via recruitment of interstitial mononuclear cells and paracrine effects rather than improved pericyte coverage of angiogen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Characterization of the arterial anatomy of the murine hindlimb: functional role in the design and understanding of ischemia models

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

Macrophages and angiogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016/J.VPH.2016.09.003

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.VPH.2016.09.003

1 reference

7 September 2017

1 reference